Skip to main content
Log in

Genome mining of Streptomyces sp. BRB081 reveals the production of the antitumor pyrrolobenzodiazepine sibiromycin

  • Genome Reports
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

Employing a genome mining approach, this work aimed to further explore the secondary metabolism associated genes of Streptomyces sp. BRB081, a marine isolate. The genomic DNA of BRB081 was sequenced and assembled in a synteny-based pipeline for biosynthetic gene clusters (BGCs) annotation. A total of 27 BGCs were annotated, including a sibiromycin complete cluster, a bioactive compound with potent antitumor activity. The production of sibiromycin, a pyrrolobenzodiazepine, was confirmed by the analysis of obtained BRB081 extract by HPLC–MS/MS, which showed the presence of the sibiromycin ions themselves, as well as its imine and methoxylated forms. To verify the presence of this cluster in other genomes available in public databases, a genome neighborhood network (GNN) was constructed with the non-ribosomal peptide synthetase (NRPS) gene from Streptomyces sp. BRB081. Although the literature does not report the occurrence of the sibiromycin BGC in any other microorganism than Streptosporangium sibiricum, we have located this BGC in 10 other genomes besides the BRB081 isolate, all of them belonging to the Actinomycetia class. These findings strengthen the importance of uninterrupted research for new producer strains of secondary metabolites with uncommon biological activities. These results reinforced the accuracy and robustness of genomics in the screening of natural products. Furthermore, the unprecedented nature of this discovery confirms the unknown metabolic potential of the Actinobacteria phylum and the importance of continuing screening studies in this taxon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

Download references

Acknowledgements

This study is registered in the Sistema Nacional de Gestão do Patrimônio Genético e do Conhecimento Tradicional Associado (SisGen # A0031D5) within the Brazilian Environmental Ministry, and has been authorized by Instituto Florestal, within the São Paulo State Environmental Secretary (process # 260108 – 004.258/2018).

Funding

This research was supported by São Paulo Research Foundation (FAPESP) grants 2017/16606-6 and 2015/17177-6, CAPES (Finance Code 001, Brazil), and Pró-Reitoria de Pesquisa da USP (PIPAE 2021.1.10424.1.9). L.V.C.L. and M.J.P.F were funded by a fellowship from Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq. V.M.B.L. were funded by a fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—CAPES.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriel Padilla.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest in the publication. This research does not involve human/ animal participants.

Additional information

Accession numbers: This whole genome shotgun sequencing project of Streptomyces sp. BRB081 is available from GenBank under the accession JACVQE000000000.2. This project can be accessed directly through the link (https://www.ncbi.nlm.nih.gov/nuccore/JACVQE000000000.2/).

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 833 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leite, V.M.B., Garrido, L.M., Tangerina, M.M.P. et al. Genome mining of Streptomyces sp. BRB081 reveals the production of the antitumor pyrrolobenzodiazepine sibiromycin. 3 Biotech 12, 249 (2022). https://doi.org/10.1007/s13205-022-03305-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-022-03305-0

Keywords

Navigation